Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigaciò Biomèdica de Bellvitge (IDIBELL) Barcelona, Spain.
Nephrol Dial Transplant. 2011 Sep;26(9):2899-906. doi: 10.1093/ndt/gfq798. Epub 2011 Jan 27.
Although infection remains among the most common causes of morbidity and mortality in patients with chronic kidney disease (CKD), data on epidemiology, clinical features and outcomes of pneumonia in this population are scarce.
Observational analysis of a prospective cohort of hospitalized adults with pneumonia, between 13 February 1995 and 30 April 2010, in a tertiary teaching hospital. CKD patients, defined as patients with a baseline glomerular filtration rate <60 mL/min/1.73 m(2), were compared with non-CKD patients.
During the study period, 3800 patients with pneumonia required hospitalization. Two-hundred and three (5.3%) patients had CKD, of whom 46 were on dialysis therapy. Patients with CKD were older (77 versus 70 years; P < 0.001), were more likely to have comorbidities (82.3 versus 63.3%; P < 0.001) and more commonly classified into high-risk pneumonia severity index classes (89.6 versus 57%; P < 0.001) than were the remaining patients. Streptococcus pneumoniae was the most frequent pathogen (28.1 versus 34.7%; P = 0.05). Mortality was higher in patients with CKD (15.8 versus 8.3%; P < 0.001). Among CKD patients, age [+1 year increase; adjusted odds ratio, 1.25; 95% confidence interval (CI) 1.07-1.46] and cardiac complications during hospitalization (adjusted odds ratio, 9.23; 95% CI 1.39-61.1) were found to be independent risk factors for mortality, whereas prior pneumococcal vaccination (adjusted odds ratio, 0.05; 95% CI 0.005-0.69) and leukocytosis at hospital admission (adjusted odds ratio, 0.10; 95% CI 0.01-0.64) were protective factors.
Pneumonia is a serious complication in CKD patients. Independent factors for mortality are older age and cardiac complications, whereas prior pneumococcal vaccination and leucokytosis at hospital admission are protective factors. These findings should encourage physicians to increase pneumococcal vaccine coverage among CKD patients.
尽管感染仍然是慢性肾脏病(CKD)患者发病率和死亡率的最常见原因之一,但有关该人群肺炎的流行病学、临床特征和结局的数据却很少。
对 1995 年 2 月 13 日至 2010 年 4 月 30 日期间在一家三级教学医院住院的肺炎成年患者进行前瞻性队列观察分析。将 CKD 患者定义为肾小球滤过率基线<60 mL/min/1.73 m2的患者,并与非 CKD 患者进行比较。
在研究期间,3800 名肺炎患者需要住院治疗。203 名(5.3%)患者患有 CKD,其中 46 名正在接受透析治疗。CKD 患者年龄更大(77 岁比 70 岁;P<0.001),合并症更多(82.3%比 63.3%;P<0.001),更常归入高风险肺炎严重指数类别(89.6%比 57%;P<0.001)。肺炎链球菌是最常见的病原体(28.1%比 34.7%;P=0.05)。CKD 患者的死亡率更高(15.8%比 8.3%;P<0.001)。在 CKD 患者中,年龄(每增加 1 岁;调整后的优势比,1.25;95%置信区间[CI]1.07-1.46)和住院期间的心脏并发症(调整后的优势比,9.23;95%CI 1.39-61.1)是死亡的独立危险因素,而肺炎球菌疫苗接种史(调整后的优势比,0.05;95%CI 0.005-0.69)和入院时白细胞增多(调整后的优势比,0.10;95%CI 0.01-0.64)是保护因素。
肺炎是 CKD 患者的严重并发症。死亡的独立危险因素是年龄较大和心脏并发症,而肺炎球菌疫苗接种和入院时白细胞增多是保护因素。这些发现应鼓励医生增加 CKD 患者的肺炎球菌疫苗接种覆盖率。